Dimitri E. Grigoriadis is Chief Research Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 82,273 shares of NBIX, which is worth approximately $10.5 Million. The most recent transaction as insider was on Oct 07, 2021, when has been sold 8,000 shares (Common Stock) at a price of $104.8 per share, resulting in proceeds of $838,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.3K
0% 3M change
0% 12M change
Total Value Held $10.5 Million

Dimitri E. Grigoriadis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 07 2021
SELL
Open market or private sale
$838,400 $104.8 p/Share
8,000 Reduced 8.86%
82,273 Common Stock
Oct 07 2021
BUY
Exercise of conversion of derivative security
$216,200 $43.24 p/Share
5,000 Added 5.42%
87,273 Common Stock
Feb 08 2021
SELL
Open market or private sale
$315,997 $116.69 p/Share
2,708 Reduced 3.08%
85,273 Common Stock
Feb 05 2021
SELL
Open market or private sale
$68,825 $113.76 p/Share
605 Reduced 0.73%
82,169 Common Stock
Nov 12 2020
SELL
Open market or private sale
$204,778 $90.73 p/Share
2,257 Reduced 2.69%
81,624 Common Stock
DEG

Dimitri E. Grigoriadis

Chief Research Officer
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX